These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10750146)

  • 1. Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome.
    Pinar Bermúdez E; García-Alberola A; Martínez Sánchez J; Sánchez Muñoz JJ; Valdés Chávarri M
    Pacing Clin Electrophysiol; 2000 Mar; 23(3):407-9. PubMed ID: 10750146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typical ECG changes unmasked by ajmaline in a patient with Brugada syndrome and left bundle branch block.
    Ozin B; Atar I; Altunkeser B; Ertan C; Yildirir A; Müderrisoğlu H
    Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):378-81. PubMed ID: 16029391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation induction and diffuse abnormal ST-segment response to ajmaline in a patient with apparent pre-existing dynamic right bundle branch block.
    Nguyen BL; Tufano F; De Angelis S; Tersigni F; Alessandri N; Brugada P
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3115-9. PubMed ID: 25392113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
    Karaca M; Dinckal MH
    Acta Cardiol; 2006 Aug; 61(4):481-4. PubMed ID: 16970061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy.
    Peters S; Trümmel M; Denecke S; Koehler B
    Int J Cardiol; 2004 Jun; 95(2-3):207-10. PubMed ID: 15193821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
    Eckardt L; Bruns HJ; Paul M; Kirchhof P; Schulze-Bahr E; Wichter T; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):742-9. PubMed ID: 12212690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient local changes in right ventricular monophasic action potentials due to ajmaline in a patient with Brugada Syndrome.
    Eckardt L; Kirchhof P; Johna R; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):1010-5. PubMed ID: 10413381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
    Miyazaki T; Mitamura H; Miyoshi S; Soejima K; Aizawa Y; Ogawa S
    J Am Coll Cardiol; 1996 Apr; 27(5):1061-70. PubMed ID: 8609322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual response to the ajmaline test in a patient with Brugada syndrome.
    Castro Hevia J; Dorticos Balea F; Dorantes Sánchez M; Zayas Molina R; Quiñones Pérez MA
    Europace; 2003 Oct; 5(4):371-3. PubMed ID: 14753634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monomorphic ventricular tachycardia during the ajmaline test].
    Akpınar O; Kurt K; Kanadaşı M
    Turk Kardiyol Dern Ars; 2013 Sep; 41(6):537-40. PubMed ID: 24104982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brugada-Brugada syndrome. An atypical case].
    Breuer HW; Breithardt G; Borggrefe M
    Z Kardiol; 1999 Jul; 88(7):467-72. PubMed ID: 10467645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete bundle-branch block and ST-segment elevation: syndrome associated with sustained monomorphic ventricular tachycardia in patients with apparently normal heart.
    Brembilla-Perrot B; Beurrier D; Jacquemin L; Kubler L; Brouant B; Demoulin S; Lucron H; Danchin N
    Clin Cardiol; 1997 Apr; 20(4):407-10. PubMed ID: 9098605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
    Scherr D; Brunner G; Kaufmann P; Lercher P; Lueger A; Rotman B; Smolle KH; Stark G; Klein W; Krejs GJ
    Intensive Care Med; 2002 Jun; 28(6):789-92. PubMed ID: 12107687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease.
    Brugada J; Brugada R; Brugada P
    Circulation; 1998 Feb; 97(5):457-60. PubMed ID: 9490240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Brugada syndrome a distinct clinical entity?
    Scheinman MM
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):332-6. PubMed ID: 9083884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.